A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab
A 76-year-old man was admitted to our hospital with cough and dyspnea. He was diagnosed with advanced lung cancer. Nivolumab was given as second-line treatment, cytotoxic chemotherapy was given as third-line treatment, and nivolumab re-challenge was given as fourth-line treatment. Thereafter, 41 che...
Main Authors: | Keima Ito, Tetsuya Oguri, Norihisa Takeda, Kensuke Fukumitsu, Satoshi Fukuda, Yoshihiro Kanemitsu, Tomoko Tajiri, Hirotsugu Ohkubo, Masaya Takemura, Ken Maeno, Yutaka Ito, Akio Niimi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Respiratory Medicine Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007119303405 |
Similar Items
-
An autopsy case of immune-related severe colitis due to long-term use of nivolumab in a patient with non-small cell lung cancer
by: Masashi Fujikawa, et al.
Published: (2022-01-01) -
Reflux-related symptoms reflect poor asthma control and the presence of airway neuronal dysfunction
by: Ryota Kurokawa, et al.
Published: (2022-07-01) -
Functional gastrointestinal disorders are associated with capsaicin cough sensitivity in severe asthma
by: Keima Ito, et al.
Published: (2023-04-01) -
Decreased capsaicin cough reflex sensitivity predicts hospitalisation due to COPD
by: Yutaka Ito, et al.
Published: (2023-07-01) -
Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: A prospective, observational study
by: Tomoko Tajiri, et al.
Published: (2024-07-01)